J Hum Hypertens. 2007 Jan;21(1):53-9. Epub 2006 Oct 12. Use of antihypertensive and lipid-lowering drugs: the management of cardiovascular risk in clinical practice. Di Martino M, Esposti LD, Filigheddu F, Veronesi C, Salerno G, Saragoni S, Glorioso N, Didoni G, Esposti ED. Source Statistics Department 'P. Fortunati', University of Bologna, Bologna, Italy. dimartino@stat.unibo.it Abstract The objective of the study was to analyse the treatment of high blood pressure (BP) and hypercholesterolaemia, as well as the effect of individual or combined antihypertensive-hypocholesterolaemic therapy on BP control and on circulating cholesterol. A retrospective study was performed using clinical data recorded in the general practitioner's database. The sample included all patients, aged > or =18 years, with BP reading or low-density lipoprotein (LDL) cholesterol measurement recorded between January 2003 and December 2004. BP and LDL cholesterol targets were defined using cutoffs based on the guidelines of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC7) and the National Cholesterol Education Program (NCEP/ATPIII). The study included 4764 patients (mean age 67.6+/-11.8 years, 43.5% males). Target BP was achieved in a higher number of patients under combined antihypertensive-hypocholesterolaemic therapy than in those treated only with antihypertensives: 57.0 vs 50.0% in patients with history of cardio/cerebrovascular (CV) hospitalization, 27.0 vs 16.9% in patients with diabetes or chronic renal insufficiency (CRI) and 59.7 vs 49.1% in patients with no CV hospitalization nor diabetes and nor CRI. The LDL cholesterol target was achieved in 61.3% of the subjects: it was independent on the therapy (individual or combined), but related to the degree of cardiovascular risk. Analysing the data contained in the general medicine database made it possible to evaluate the treatment of high BP and hypercholesterolaemia in relation to cardiovascular risk in clinical practice and to establish the need to pay greater attention to achieving the objective set by guidelines. PMID: 17036042 [PubMed - indexed for MEDLINE]

Use of antihypertensive and lipid-lowering drugs: the management of cardiovascular risk in clinical practice / Di Martino, M; Esposti, Ld; Filigheddu, Fabiana; Veronesi, C; Salerno, G; Saragoni, S; Glorioso, Nicola Filippo; Didoni, G; Esposti, E. D.. - In: JOURNAL OF HUMAN HYPERTENSION. - ISSN 0950-9240. - 21:1(2007), pp. 53-59.

Use of antihypertensive and lipid-lowering drugs: the management of cardiovascular risk in clinical practice

FILIGHEDDU, Fabiana;GLORIOSO, Nicola Filippo;
2007

Abstract

J Hum Hypertens. 2007 Jan;21(1):53-9. Epub 2006 Oct 12. Use of antihypertensive and lipid-lowering drugs: the management of cardiovascular risk in clinical practice. Di Martino M, Esposti LD, Filigheddu F, Veronesi C, Salerno G, Saragoni S, Glorioso N, Didoni G, Esposti ED. Source Statistics Department 'P. Fortunati', University of Bologna, Bologna, Italy. dimartino@stat.unibo.it Abstract The objective of the study was to analyse the treatment of high blood pressure (BP) and hypercholesterolaemia, as well as the effect of individual or combined antihypertensive-hypocholesterolaemic therapy on BP control and on circulating cholesterol. A retrospective study was performed using clinical data recorded in the general practitioner's database. The sample included all patients, aged > or =18 years, with BP reading or low-density lipoprotein (LDL) cholesterol measurement recorded between January 2003 and December 2004. BP and LDL cholesterol targets were defined using cutoffs based on the guidelines of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure (JNC7) and the National Cholesterol Education Program (NCEP/ATPIII). The study included 4764 patients (mean age 67.6+/-11.8 years, 43.5% males). Target BP was achieved in a higher number of patients under combined antihypertensive-hypocholesterolaemic therapy than in those treated only with antihypertensives: 57.0 vs 50.0% in patients with history of cardio/cerebrovascular (CV) hospitalization, 27.0 vs 16.9% in patients with diabetes or chronic renal insufficiency (CRI) and 59.7 vs 49.1% in patients with no CV hospitalization nor diabetes and nor CRI. The LDL cholesterol target was achieved in 61.3% of the subjects: it was independent on the therapy (individual or combined), but related to the degree of cardiovascular risk. Analysing the data contained in the general medicine database made it possible to evaluate the treatment of high BP and hypercholesterolaemia in relation to cardiovascular risk in clinical practice and to establish the need to pay greater attention to achieving the objective set by guidelines. PMID: 17036042 [PubMed - indexed for MEDLINE]
Use of antihypertensive and lipid-lowering drugs: the management of cardiovascular risk in clinical practice / Di Martino, M; Esposti, Ld; Filigheddu, Fabiana; Veronesi, C; Salerno, G; Saragoni, S; Glorioso, Nicola Filippo; Didoni, G; Esposti, E. D.. - In: JOURNAL OF HUMAN HYPERTENSION. - ISSN 0950-9240. - 21:1(2007), pp. 53-59.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11388/81721
Citazioni
  • ???jsp.display-item.citation.pmc??? 17
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact